1. Revishvili ASh, Shlyakhto EV, Sulimov VA, Rzaev FG, Gorev MV, Nardaya ShG, Shpektor AV, Golicyn SP, Popov SV, Shubik YuV, Yashin SM, Mihajlov EN, Pokushalov EA, Gilyarov MYu, Lebedev DS, Andreev DA, Batalov RE, Pidanov OYu, Medvedev MM, Novikova NA, Obrezan AG, Panchenko EP, Sveshnikov AV, Shahmatova OO, Yavelov IS. Diagnostika i lechenie fibrillyacii predserdij. Klinicheskie rekomendacii. M.: Vserossijskoe nauchnoe obshchestvo specialistov po klinicheskoj elektrofiziologii, aritmologii i kardiostimulyacii; 2017. (In Russ.)
2. Sulimov VA, Golitsyn SP, Blagova OV, Nedostup AV. Diagnostics and management of atrial fibrillation recommendations RSC, RSSA and ACVS. Racional’naya farmakoterapiya v kardiologii. 2011;7(4):5-84. (In Russ.)
3. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study
4. Shkolnikova MA, Jdanov DA, Ildarova RA, Shcherbakova NV, Polyakova EB, Mikhaylov EN, Shalnova SA, Shkolnikov VM. Atrial fibrillation among Russian men and women aged 55 years and older: prevalence, mortality, and associations with biomarkers in a population-based study. Journal of Geriatric Cardiology: JGC. 2020;17(2):74-84
5. Autoantibodies to M2-cholinoreceptors as a potential development factor of arrhythmia in patients with paroxysmal atrial fibrillation